Open AccessDual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity
Author(s) -
Yuki Fujimoto,
Kosuke Kaji,
Norihisa Nishimura,
Masahide Enomoto,
Kōji Murata,
Soichi Takeda,
Hiroaki Takaya,
Hideto Kawaratani,
Kyoji Moriya,
Tadashi Namisaki,
Takemi Akahane,
Hitoshi Yoshiji
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i48.8323
Subject(s) - rifaximin , alcoholic liver disease , hepatic fibrosis , medicine , cirrhosis , fibrosis , oxidative stress , liver injury , hepatic stellate cell , kupffer cell , endocrinology , proinflammatory cytokine , chemistry , inflammation , biochemistry , antibiotics